Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) has a cash flow conversion efficiency ratio of -0.001x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-158.03K) by net assets ($196.19 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see OACC market cap for the company's overall valuation and market capitalisation.
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share - Cash Flow Conversion Efficiency Trend (2024–2025)
This chart illustrates how Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share ranked by their cash flow conversion efficiency. Explore OACC cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Celon Pharma SA
WAR:CLN
|
-0.009x |
|
SCI Pharmtech Inc
TW:4119
|
0.030x |
|
Azkoyen
MC:AZK
|
0.141x |
|
Limoneira Co
NASDAQ:LMNR
|
-0.027x |
|
EMS Limited
NSE:EMSLIMITED
|
-0.029x |
|
S H Kelkar and Company Limited
NSE:SHK
|
0.096x |
|
Thayer Ventures Acquisition Corporation II Class A Ordinary Shares
NASDAQ:TVAI
|
-0.002x |
|
Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares
NASDAQ:AXIN
|
-0.001x |
Annual Cash Flow Conversion Efficiency for Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (2024–2025)
The table below shows the annual cash flow conversion efficiency of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share from 2024 to 2025. View Oaktree Acquisition Corp. III Life Scien (OACC) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $194.79 Million | $-422.08K | -0.002x | -353.00% |
| 2024-12-31 | $187.50 Million | $-89.69K | 0.000x | -- |
About Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in … Read more